NEWS June 2024
OBB is happy to be in partnership with RareCan and are delighted that they have been recognised for the work they are doing to increase access and uptake of clinical trials.
From RareCan CEO Piers Kotting:
“I’m delighted to share that our collaboration with brainstrust, The Brain Tumour Charity and OurBrainBank for Glioblastoma has been recognised with a Gold Award in this year’s Patient Partnership Index.
Our collaboration is about working together to improve access to clinical trials for patients with brain tumours. It’s about leveraging the strengths of each of the partners and deploying cutting edge technologies to give patients more choice and make it easier for them to exercise that choice.”